header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-FIG-150217-8
Kim et al., 2014 - Essential role of apelin signaling during lymphatic development in zebrafish. Arterioscler. Thromb. Vasc. Biol.   34(2):338-345 Full text @ Arterioscler. Thromb. Vasc. Biol.
ADDITIONAL FIGURES
EXPRESSION / LABELING:
Genes:
Fish:
Conditions:
Knockdown Reagent:
Anatomical Terms:
Stage: Day 4
PHENOTYPE:
Fish:
Conditions:
Knockdown Reagent:
Observed In:
Stage: Day 4

Fig. 4 ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Gene Expression Details
Gene Antibody Fish Conditions Stage Anatomy Assay
EGFP s896Tg; y7Tg control Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
s896Tg; y7Tg + MO1-apln chemical treatment: LY294002 Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
s896Tg; y7Tg + MO1-apln chemical treatment: torin 1 Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
s896Tg; y7Tg + MO1-apln standard conditions Day 4 blood vessel endothelial cell IFL
Day 4 lymph vessel endothelium IFL
Day 4 lymph vessel endothelium endothelial cell IFL
mCherry s896Tg; y7Tg control Day 4 blood vessel endothelial cell IFL
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 blood vessel endothelial cell IFL
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 blood vessel endothelial cell IFL
s896Tg; y7Tg + MO1-apln chemical treatment: LY294002 Day 4 blood vessel endothelial cell IFL
s896Tg; y7Tg + MO1-apln chemical treatment: torin 1 Day 4 blood vessel endothelial cell IFL
s896Tg; y7Tg + MO1-apln standard conditions Day 4 blood vessel endothelial cell IFL
Antibody Labeling Details No data available
Phenotype Details
Fish Conditions Stage Phenotype
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 lymph vessel development process quality, abnormal
Day 4 lymph vessel endothelium endothelial cell decreased amount, abnormal
s896Tg; y7Tg chemical treatment: pharmaceutical Day 4 lymph vessel development process quality, abnormal
Day 4 lymph vessel endothelium endothelial cell decreased amount, abnormal
s896Tg; y7Tg + MO1-apln chemical treatment: LY294002 Day 4 lymph vessel development process quality, abnormal
Day 4 lymph vessel endothelium endothelial cell decreased amount, abnormal
s896Tg; y7Tg + MO1-apln chemical treatment: torin 1 Day 4 lymph vessel development process quality, abnormal
Day 4 lymph vessel endothelium endothelial cell decreased amount, abnormal
s896Tg; y7Tg + MO1-apln standard conditions Day 4 lymph vessel development process quality, abnormal
s896Tg; y7Tg + MO1-apln standard conditions Day 4 lymph vessel endothelium endothelial cell decreased amount, abnormal
Full text @ Arterioscler. Thromb. Vasc. Biol.